Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Decision Diagnostics Corp (DECN) Message Board

Meanwhile only a few derogatory posts on the other

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 11803
(Total Views: 726)
Posted On: 05/12/2018 12:05:11 PM
Posted By: plutonium
Re: mrmaskedman #4897
Meanwhile only a few derogatory posts on the other board along with comments about new technology threats.

Full disclosure. I worked for over 40 years for an at-home testing kit and glucose test system company. Worldwide, my former company has over 1.2 million users. My former company is in fourth place of the Big 4.

Dexcom, Hurricane Willy's favorite company (today) has barely 8,000 users. Dexcom has spent over $170 million on their me-too technology (to date). They have a free pass, some would say an exclusive club pass, by the FDA. And barely 8,000 users.

Lifescan has over 4 million users worldwide. Roche has 3.75 million users. Dexcom isn't going to take over anything. The FDA isn't going to approve an in-vitro sensor for continuous glucose monitoring, so companies in the market will have to rely on exo-sensors. Exo-sensors don't work well. Things like mouthwash (alcohol) and even post-sex chemistry changes, make these sensors go crazy. Further, the devices that contain these sensors are expensive. Medicare doesn't like expensive.

I have two additional comments about Willy. If he knows so much, he should contact Dexcom's chairman and attempt to be elected or appointed to their BOD. Unfortunately, Willy has no industry experience, no formal education in the sciences, in fact no higher education at all, plus Willy has a nasty disposition. BODs run and hide from people like Willy.

Second and last, according to my friend Barbara Asbell, engineers should engineer, chemists should perfect chemistry, accountants should account, market researchers should publish market studies, and stock traders should trade stocks. I agree with her. In my experience, the only exception to this rule is in M&A where the M&A expert is often required to cross professional lines. Willy is none of these things. But Willy, because he is down on the stock, which is Willy's rationale for hating everything Berman, is trying to convince everyone that he knows what he is posting about. This is totally untrue. I would say shame on Willy, but it is obvious that Willy has no shame.


(4)
(1)




Decision Diagnostics Corp (DECN) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us